Tell me why I shouldnt use it

athletes subject to testing should not use this product Side Effects, Reactions & Medical Contraindications Contraindications Use is generally not recommended in: Known allergy or hypersensitivity to BPC157 or any component of the vial Pregnancy or breastfeeding (no adequate safety data) Active malignancy or history of cancer unless cleared by a specialist, due to theoretical concerns around angiogenesis and cellgrowth modulation Severe uncontrolled cardiovascular, renal, hepatic, or autoimmune disease without specialist supervision Competitive/regulated athletes subject to WADA or similar antidoping rules Common Side Effects and Adverse Reactions Local injectionsite reactions: redness, swelling, itching, bruising, pain Headache, dizziness or lightheadedness Nausea, stomach discomfort, diarrhea or constipation Fatigue, changes in energy or sleep disturbance Flushing or warmth sensations Because products are often unregulated, contamination or incorrect dosing may also contribute to side effects Reactions Requiring Medical Attention Patients should stop injections and seek urgent medical care (or emergency services, if severe) if they experience: Signs of a serious allergic reaction: widespread rash, hives, facial/tongue swelling, difficulty breathing Chest pain, severe shortness of breath or rapid heartbeat Severe or persistent abdominal pain, vomiting or bloody stools Sudden, unexplained swelling, rapid weight gain, or marked changes in blood pressure Any other new or worsening symptoms that feel serious or concerning Safety Note: Longterm data is limited

From having the energy to stay active to lowering your risks of heart disease, our programs focus goes beyond the number on the scale
La semaglutida no es para todos: desigualdades en el acceso a frmacos contra la obesidad En busca de frmacos contra la diabetes A diferencia de las promesas dudosas de algunos mtodos adelgazantes, el Ozempic y sus formatos derivados cumplen
Combining them could increase the potential risks of these serious side effects
To evaluate the healing efficacy, a comprehensive experiment was conducted on diabetic wounds treated with various agents, including: i) PBS as negative control (NC group), ii) ROS-responsive hydrogel matrix (G group), iii) monomer copper peptides M-CuP solution (M-CuP group), iv) dimeric copper peptides D-CuP solution (D-CuP group), v) ROS-responsive hydrogel with monomer copper peptides M-CuP (G/M-CuP group), and vi) ROS-responsive hydrogel with dimeric copper peptides (G/D-CuP group)